Browse by author
Lookup NU author(s): Dr Petros Perros
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2016 European Thyroid Association Published by S. Karger AG, Basel.Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease, though severe forms are rare. Management of GO is often suboptimal, largely because available treatments do not target pathogenic mechanisms of the disease. Treatment should rely on a thorough assessment of the activity and severity of GO and its impact on the patient's quality of life. Local measures (artificial tears, ointments and dark glasses) and control of risk factors for progression (smoking and thyroid dysfunction) are recommended for all patients. In mild GO, a watchful strategy is usually sufficient, but a 6-month course of selenium supplementation is effective in improving mild manifestations and preventing progression to more severe forms. High-dose glucocorticoids (GCs), preferably via the intravenous route, are the first line of treatment for moderate-to-severe and active GO. The optimal cumulative dose appears to be 4.5-5 g of methylprednisolone, but higher doses (up to 8 g) can be used for more severe forms. Shared decision-making is recommended for selecting second-line treatments, including a second course of intravenous GCs, oral GCs combined with orbital radiotherapy or cyclosporine, rituximab or watchful waiting. Rehabilitative treatment (orbital decompression surgery, squint surgery or eyelid surgery) is needed in the majority of patients when GO has been conservatively managed and inactivated by immunosuppressive treatment.
Author(s): Bartalena L, Baldeschi L, Boboridis K, Eckstein A, Kahaly GJ, Marcocci C, Perros P, Salvi M, Wiersinga WM
Publication type: Article
Publication status: Published
Journal: European Thyroid Journal
Year: 2016
Volume: 5
Issue: 1
Pages: 9-26
Online publication date: 02/03/2016
Acceptance date: 05/01/2016
ISSN (print): 2235-0640
ISSN (electronic): 2235-0802
Publisher: S. Karger AG
URL: http://doi.org/10.1159/000443828
DOI: 10.1159/000443828
Altmetrics provided by Altmetric
